Latest News:  
Beijing   Sunny    34 / 23 ℃  City Forecast

Home>>China Society

No abnormalities found in Roche Company investigations

(People's Daily Online)

08:15, July 17, 2012

Recently, U.K. media reported that the multinational pharmaceutical enterprise Roche Company is being investigated emergently by European drug supervision departments for concealing the report of 15,000 drug fatalities and 65,000 adverse drug reactions. The State Food and Drug Administration of China (SFAD) said on July 11 that it was paying close attention to this incident, and according to China's adverse drug reaction monitoring, no abnormality has been found regarding the drugs involved in the incident.

According to sources, this incident involves eight kinds of drugs, which are mainly used for treating such diseases as the mammary cancer, intestinal cancer, hepatitis, skin diseases and eye diseases.

Of these drugs, the Herceptin for treating mammary cancer, Mabthera for treating malignant lymphoma, Pegasys for treating hepatitis C, Avastin for treating rectal cancer and Tarceva for treating lung cancer are sold in China. These drugs have been in the Chinese market for several years or even more than 10 years.

The SFDA said that no abnormality has been found in China's adverse reaction monitoring on the drugs involved in this incident.

After the incident occurred, the Roche Company made a statement on July 11, saying that the incident of 15,000 adverse reactions of no safety assessment reported by the media was only limited in an U.S. project supported by patients. According to the current assessment by the Roche Company, there is no sign showing drug products of the Roche Company are unsafe.

Medical experts said that normally medicines must be tested by three institutions, namely the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA) and Medicines and the U.K. Healthcare Products Regulatory Agency (MHRA) before they are exported to China. However, these medicines must also pass through the State Food and Drug Administration of China.

As Chinese people are different with foreigners in physique characteristics, foreign data cannot be directly used in China and must pass through China's testing institutions.

Read the Chinese version: 药监局:罗氏隐瞒患者死亡涉及药品未现异常

Email|Print|Comments(Editor:黄蓓蓓、姚春)

Leave your comment0 comments

  1. Name

  

Selections for you


  1. Chinese-Indonesian "Edge 2012" anti-terrorism joint training

  2. Life of Afghan drug addicts

  3. Best time to treat your organs

  4. Flying Fork performed in Suqiao, China's Hebei

  5. Unconceivable capacity of human organs

  6. Chinese Cabbage Never Looked So Sexy

Most Popular

Opinions

  1. Europe's chances of economic recovery lie in unity
  2. Fragile peace barely holds in tense Kashmir
  3. Tokyo's islands stance harmful to ties
  4. Experts doubt legality of online auction
  5. Searching for the right professionals
  6. Clinton’s Asia trip takes economic turn
  7. Vatican needs to adapt to local systems
  8. Commercial property market a bubble to explode
  9. Assad inextricable part of peaceful transition
  10. Naval exercises routine, not warning to Japan

What's happening in China

Supermarket investigates worm-infested Cadbury candy

  1. Engines restart for "national sedan" Hongqi
  2. Three Gorges reservoir water at year's highest
  3. Chinese ships end patrol near Diaoyu Islands
  4. 2 mln affected in Chinese rainstorms
  5. For destitute old man, prison was good life

China Features

  1. Why is TCM worth of commendation?
  2. Arabians pay heavy price for Arab Spring
  3. Master of pasted-paper sculpture
  4. China, US hold mixed attitudes toward each other
  5. China does not lack capital: CSRC Chair

PD Online Data

  1. Spring Festival
  2. Chinese ethnic odyssey
  3. Yangge in Shaanxi
  4. Gaoqiao in Northern China
  5. The drum dance in Ansai